Palvella Therapeutics raises $230 million in upsized stock offering Mar 2, 2026 07:30AM
Palvella Therapeutics Announces Closing of Upsized Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares Mar 2, 2026 07:30AM
Palvella Therapeutics prices $200 million stock offering at $125 per share Feb 25, 2026 07:57PM
Palvella Therapeutics Announces Pricing of Upsized Public Offering Feb 25, 2026 07:57PM
Palvella Therapeutics launches $150 million stock offering Feb 24, 2026 04:06PM


Feb 24, 2026 04:05PM Palvella Therapeutics Announces Proposed Public Offering
Dec 15, 2025 12:29PM Palvella Therapeutics (PVLA) PT Raised to $204 at Canaccord Genuity
Oct 9, 2025 06:36AM Palvella Therapeutics (PVLA) PT Raised to $90 at Canaccord Genuity
Aug 19, 2025 06:18AM Palvella Therapeutics (PVLA) PT Raised to $66 at Canaccord Genuity
Aug 5, 2025 07:30AM Palvella Therapeutics to Participate in the Canaccord Genuity 45th Annual Growth Conference